Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells

Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells

US Patent 5834256 · Granted Nov 10, 1998

Estimated economic value: $1,983,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for preventing money laundering using master smart contract 2025
Oncolytic viral vectors and uses thereof2025
Oncolytic viral delivery of therapeutic polypeptides2024
Oncolytic viral vectors and uses thereof2023
Oncolytic viral vectors and uses thereof2022
Oncolytic viral delivery of therapeutic polypeptides2021
Oncolytic viral vectors and uses thereof2019
Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy2017
Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy2015
Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy2014
Method and means for producing high titer, safe recombinant lentivirus vectors2014
Method and means for producing high titer, safe recombinant lentivirus vectors2014